Literature DB >> 9726662

Highly selective sigma receptor ligands elevate inositol 1,4,5-trisphosphate production in rat cardiac myocytes.

M Novakova1, C Ela, W D Bowen, Y Hasin, Y Eilam.   

Abstract

Exposure of cardiac myocytes from adult rat ventricles to the highly selective, high affinity sigma receptor ligands 1S,2 R-cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)-cycloh exylamine (BD-737) (0.1-100 nM) and N-[2-(3,4-dichlorophenyl)ethyl]-N,N',N'-trimethylethylenediamine (BD-1047) (0.01-10 nM), caused potentiation of electrically-evoked amplitudes of contraction and Ca2+ transients, while exposure to 100 nM BD-1047 caused attenuation of these amplitudes. In addition, BD-737 (1-100 nM) and BD-1047 (10-100 nM) caused an increase in the incidence of spontaneous twitches. These effects were inhibited when the incubation with BD-737 was done in the presence of the phospholipase C inhibitor, neomycin, or after pre-incubation with thapsigargin or caffeine which deplete the sarcoplasmic reticulum Ca2+ stores. Inositol 1,4,5-trisphosphate (IP3) production in cardiac myocytes was determined by the IP3 binding protein assay. Both substances caused an increase in the intracellular concentration of IP3. BD-737 caused a rapid transient increase to 3.2-fold in 1 min and stabilization at 2.1-fold of control thereafter. BD-1047 caused a gradual increase reaching 4.4-fold after 5 min. The results suggest that the effects of these sigma receptor ligands on contractility and spontaneous contractions are mediated by activation of phospholipase C and elevation of intracellular IP3 level.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9726662     DOI: 10.1016/s0014-2999(98)00398-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  18 in total

Review 1.  Sigma receptors: biology and therapeutic potential.

Authors:  Xavier Guitart; Xavier Codony; Xavier Monroy
Journal:  Psychopharmacology (Berl)       Date:  2004-06-10       Impact factor: 4.530

Review 2.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

3.  The sigma receptor: evolution of the concept in neuropsychopharmacology.

Authors:  T Hayashi; Tp Su
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

Review 4.  Sigma-1 receptor chaperones and diseases.

Authors:  Shang-Yi Tsai; Teruo Hayashi; Tomohisa Mori; Tsung-Ping Su
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2009-09

5.  The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements.

Authors:  Arindam Pal; Dominique Fontanilla; Anupama Gopalakrishnan; Young-Kee Chae; John L Markley; Arnold E Ruoho
Journal:  Eur J Pharmacol       Date:  2012-02-22       Impact factor: 4.432

6.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

7.  Antidiarrhoeal properties of a novel sigma ligand (JO 2871) on toxigenic diarrhoea in mice: mechanisms of action.

Authors:  V Theodorou; M Chovet; H Eutamene; H Fargeau; M Dassaud; M Toulouse; C Bihoreau; F J Roman; L Bueno
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

8.  Diabetes decreases mRNA levels of calcium-release channels in human atrial appendage.

Authors:  Sahika Guner; Ebru Arioglu; Aydin Tay; Atalay Tasdelen; Sait Aslamaci; Keshore R Bidasee; U Deniz Dincer
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

9.  Voltage-gated sodium channel modulation by sigma-receptors in cardiac myocytes and heterologous systems.

Authors:  Molly Johannessen; Subramaniam Ramachandran; Logan Riemer; Andrea Ramos-Serrano; Arnold E Ruoho; Meyer B Jackson
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-11       Impact factor: 4.249

Review 10.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.